NASDAQ:AEMD Aethlon Medical (AEMD) Stock Price, News & Analysis $5.29 -0.29 (-5.20%) Closing price 11/13/2026 04:00 PM EasternExtended Trading$5.30 +0.00 (+0.09%) As of 11/13/2026 04:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsNews and TrendsOwnershipSEC Filings About Aethlon Medical Stock (NASDAQ:AEMD) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Aethlon Medical alerts:Sign Up Key Stats Today's Range$5.21▼$5.6450-Day Range$1.43▼$6.8152-Week Range$1.41▼$25.66Volume26,471 shsAverage Volume46,192 shsMarket Capitalization$3.76 millionP/E RatioN/ADividend YieldN/APrice Target$1.50Consensus RatingReduce Company Overview Aethlon Medical, Inc. is a biotechnology and medical-device company focused on developing extracorporeal blood filtration technologies for life-threatening diseases. The company’s lead product candidate, the Hemopurifier, is designed to selectively remove harmful substances from the bloodstream, including cancer-promoting exosomes and certain viral particles. The Hemopurifier is intended to be used with standard dialysis or blood-circulation equipment and is being investigated for potential applications in oncology and infectious disease. Aethlon has studied the technology in connection with solid tumors and viral infections, including diseases in which circulating pathogens or exosomes may contribute to disease progression. The device remains investigational and is not broadly approved as a commercial treatment. Founded in 2001 and headquartered in San Diego, California, Aethlon Medical has conducted its development activities through collaborations and clinical studies in the United States and other regions. The company’s programs and leadership may change as clinical development progresses; its primary focus remains advancing the Hemopurifier and related blood-purification applications.AI Generated. May Contain Errors. Read More Aethlon Medical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks22nd Percentile Overall ScoreAEMD MarketRank™: 1.10268149117 of 5 starsAethlon Medical scored higher than 22% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.2 / 5Analyst RatingReduce Consensus RatingAethlon Medical has received a consensus rating of Reduce. The company's average rating score is 1.50, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and 1 sell rating.Downside RiskAethlon Medical has a consensus price target of $1.50, representing about 71.6% downside from its current price of $5.29.Amount of Analyst CoverageAethlon Medical has only been the subject of 2 research reports in the past 90 days.Read more about Aethlon Medical's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Aethlon Medical are expected to grow in the coming year, from ($5.74) to ($0.57) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Aethlon Medical is -0.15, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Aethlon Medical is -0.15, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAethlon Medical has a P/B Ratio of 0.34. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted6.11% of the float of Aethlon Medical has been sold short.Short Interest Ratio / Days to CoverAethlon Medical has a short interest ratio ("days to cover") of 0.76, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Aethlon Medical has recently increased by 31.16%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAethlon Medical does not currently pay a dividend.Dividend GrowthAethlon Medical does not have a long track record of dividend growth. News and Social Media3.9 / 5News Sentiment1.20 News SentimentAethlon Medical has a news sentiment score of 1.20. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.57 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Aethlon Medical this week, compared to 3 articles on an average week.Search InterestOnly 2 people have searched for AEMD on MarketBeat in the last 30 days. This is a decrease of -78% compared to the previous 30 days.MarketBeat Follows1 people have added Aethlon Medical to their MarketBeat watchlist in the last 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Aethlon Medical insiders have not sold or bought any company stock.Percentage Held by Insiders0.60% of the stock of Aethlon Medical is held by insiders.Percentage Held by Institutions1.99% of the stock of Aethlon Medical is held by institutions.Read more about Aethlon Medical's insider trading history. Receive AEMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aethlon Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AEMD Stock News HeadlinesAethlon Medical Reports Second Quarter Fiscal 2027 Results and Provides Corporate UpdateNovember 12 at 4:30 PM | prnewswire.comAethlon Medical (AEMD) Set to Announce Earnings on WednesdayNovember 10, 2026 | americanbankingnews.comMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each warning issued before the crisis hit. Now the founder of Weiss Ratings, the only conflict-free rating agency in America, says he is watching a $3 trillion problem that could trigger a chain reaction across markets and banks.November 14 at 1:00 AM | Weiss Ratings (Ad)Aethlon Medical IncOctober 21, 2026 | money.usnews.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Aethlon Medical (AEMD), Xenon (XENE) and Oculis Holding (OCS)September 19, 2026 | theglobeandmail.comSHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Aethlon Medical, Inc. (NASDAQ: AEMD)September 18, 2026 | prnewswire.comAethlon stock pulls back: What's going on?September 18, 2026 | msn.comAethlon Medical Shares Surge Over 470% On North Immunology Merger, $180M FinancingSeptember 17, 2026 | rttnews.comSee More Headlines AEMD Stock Analysis - Frequently Asked Questions How have AEMD shares performed this year? Aethlon Medical's stock was trading at $13.85 at the start of the year. Since then, AEMD shares have decreased by 61.8% and is now trading at $5.29. How were Aethlon Medical's earnings last quarter? Aethlon Medical, Inc. (NASDAQ:AEMD) announced its earnings results on Thursday, November, 12th. The medical equipment provider reported ($2.60) EPS for the quarter, beating analysts' consensus estimates of ($2.70) by $0.10. When did Aethlon Medical's stock split? Shares of Aethlon Medical reverse split on Thursday, October 5th 2023.The 1-10 reverse split was announced on Wednesday, October 4th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, October 4th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. How do I buy shares of Aethlon Medical? Shares of AEMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Aethlon Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Aethlon Medical investors own include NVIDIA (NVDA), Plug Power (PLUG), Advanced Micro Devices (AMD), Novavax (NVAX), Intel (INTC), NIO (NIO) and Nokia (NOK). Company Calendar Last Earnings11/12/2026Today11/14/2026Fiscal Year End3/31/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (1m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 AEMD's financial health is in the Green zone, according to TradeSmith. AEMD has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:AEMD CIK882291 Webwww.aethlonmedical.com Phone(619) 941-0360FaxN/AEmployees9Year Founded1998Price Target and Rating Average Price Target for Aethlon Medical$1.50 High Price Target$1.50 Low Price Target$1.50 Potential Upside/Downside-71.6%Consensus RatingReduce Rating Score (0-4)1.50 Research Coverage2 Analysts Profitability EPS (Trailing Twelve Months)($34.97) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$7.15 million Net MarginsN/A Pretax MarginN/A Return on Equity-144.09% Return on Assets-117.35% Debt Debt-to-Equity RatioN/A Current Ratio5.42 Quick Ratio5.42 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$15.56 per share Price / Book0.34Miscellaneous Outstanding Shares710,000Free Float707,000Market Cap$3.76 million OptionableNo Data Beta1.27 Social Links 10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free Report This page (NASDAQ:AEMD) was last updated on 11/13/2026 by MarketBeat.com Staff. From Our PartnersWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | SponsoredURGENT: If you own a home, please review the map below.More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards...Paradigm Press | SponsoredThe SpaceX Play Nobody Is Talking AboutA 30-year veteran who called Tesla before it soared 1,216% is spotlighting a company operating in the shadows ...StocksToTrade | SponsoredManagement just bought 2.8 million sharesManagement just backed a $100 million buyback, repurchasing 2.8 million shares at an average price of $35.26 i...Monument Traders Alliance | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aethlon Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aethlon Medical With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AEMD Stock Alerts